William Blair 30 th Annual Growth Stock Conference

Size: px
Start display at page:

Download "William Blair 30 th Annual Growth Stock Conference"

Transcription

1 William Blair 30 th Annual Growth Stock Conference June 2010

2 Forward-Looking Statements This presentation may contain forward-looking statements within the meaning of the safe harbor provisions of the Securities Litigation Reform Act of Terms such as expect, believe, continue, going forward, and grow, as well as similar comments, are forward-looking in nature. Actual results may differ from these forward-looking statements and the company can give no assurances that such expectations can be attained. Factors that could cause actual results to differ materially from the Company s expectation include: general business and economic conditions, competitive factors, raw materials purchasing, and fluctuations in demand. Please refer to the Company s Securities and Exchange Commission filings for further information. 2

3 Investment Highlights Becoming a leading brand in the broader functional foods sector through a robust product line-up beyond margarine spreads Well positioned to capitalize on the growing healthy foods market and trends like aging population, increasing obesity levels, and general awareness of health issues Only naturally trans fat free margarine on the market with patented technology Grown into the #2 player in the margarine category in just 10 years Virtual company model that generates significant free cash flow and has limited capital requirements Quality and experienced management team with promotional and brand building expertise 3

4 Growth Strategy Grow margarine spreads market share via three-tier strategy Use Smart Balance, Earth Balance, and BestLife brands, to appeal to a wider range of consumers Gain market share in other existing products National rollout of enhanced milk a category that is ten times larger than spreads Introduce new products Establish Smart Balance as an umbrella brand that creates crossover consumer loyalty and can support a broad number of products in various categories 4

5 Leverage Operating Model for Future Growth Create umbrella brands to support healthy living and to serve the health needs of target populations with great tasting food solutions Heart Health Diabetes Senior Nutrition Osteoporosis & Osteopenia Kids Nutrition Obesity BetterFor-You Foods Sports Nutrition Celiac Disease Lactose Intolerance 5

6 Updated 2010 Outlook Net sales growth in the 2% to 4% range for full-year 2010, compared to previous outlook for mid-teens growth Cash operating income* flat year-over-year for full-year 2010, compared to previous outlook for mid-teens growth For 2Q 2010, net sales decline in the 6% to 7% range For 2H 2010, net sales growth in the 5% to 10% range Updated outlook based on combined effects of Continued macroeconomic softness Consumer price sensitivity for premium products Heightened competitive promotional activity in spreads Slower than anticipated growth in new categories *Cash operating income excludes previously announced reorganization charges and potential impairment charges resulting from the updated outlook for **For additional details on the updated 2010 outlook, refer to the Company s press release dated June 14,

7 Three Tier Brands Target Different Consumers Products in all segments of the spreads category Positioning Heart health, all natural ingredients Heart health Good health, weight management Consumer target Consumer seeking heart health and/ or natural ingredients Consumer seeking heart health Consumer seeking value and overall healthy products Demographics Younger skew Higher income Older skew Higher income Family Value Moderate income Pricing - typical base Super Premium $4.29 Premium $3.29 Value $ % 64% 48% Oil content 7

8 Market Share Continues to Grow Smart Balance Family of Spreads 52 Week Dollar Market Share Source: IRI U.S. Food, data through

9 Smart Balance HeartRight Spreads The first spread to incorporate heart-healthy long-chain Omega-3 fatty acids with cholesterol reducing phytosterols Patented blend that supports healthy cholesterol levels DHA/EPA & ALA Omega 3: Helps promote heart health Vitamin E: Potent antioxidant Phytosterols: Helps reduce cholesterol 9

10 Earth Balance Natural Buttery Spreads Natural ingredient profile Certified non-gmo ingredients Gluten free, lactose free, vegan No partially hydrogenated oils No artificially modified oils Largest distribution in health channel YTD shipments +30% 10

11 Bestlife Buttery Spreads First value brand with no partially hydrogenated oils No palm kernel oil Excellent source of Vitamin D Start shipping Q Current distribution 45%, including Wal-Mart Buttery Spray 8oz Buttery Spread 15oz Buttery Spread With Extra Virgin Olive Oil 15oz Buttery Spread 45oz 11

12 Bestlife Brand Strategy Smart Balance has an exclusive global license to use the Bestlife brand in virtually every food & beverage category CONCEPT Create portfolio of Bestlife food and beverage products, with lifestyle positioning beyond heart healthy LAUNCH Introduce Bestlife Buttery Spreads and Spray to play in untapped $.6 billion value segment EXPANSION Enter additional food and beverage categories, mostly sublicensed, based on fit with Bob Greene nutrition plan and consumer needs 12

13 Bestlife Brand and Bob Greene Bob Greene is Oprah s personal trainer and nutrition and fitness expert Author of books on diet, fitness, and nutrition over 10 million copies sold Created the Best Life healthy lifestyle program includes eliminating trans fats and reducing saturated fats from dairy Best Life seal of approval on 22 brands in 22 categories - $3.5 billion in retail sales 1 1. Source: IRI 13

14 Bestlife Media Strategy Target Media at confluence of most likely early adopters and most efficient spend Start with Best Life opt-ins and move through balance of Oprah media platforms Oprah Show 50MM Oprah.com 20MM O Magazine 3.5MM Best Life Opt-Ins 1.5MM 14

15 Dairy Initiative Driven by Milk Exceptional benefits and great taste: Enhanced Milks: Varieties that include an excellent source of DHA/EPA Omega-3s, Antioxidant Vitamin E and even plant sterols Sour Creams: An excellent source of Vitamins A, D & E and DHA/ EPA Omega-3s as well as a good source of calcium Expanding across U.S. in 2010 Milk in 63% distribution through May 15

16 Healthy Premium Milks Outpacing Category Enhanced milk fastest growing segment in 2009 due to the introduction of Smart Balance milk 2009 Avg % Change % Change Items/Store '09 vs '04 '09 YTD vs PY Milk Category % 4% Healthy Premium Segment % 7% Enhanced Milk % 61% Organic Milk % (5%) Soy Milk % 1% Lactose-free Milk % 5% Source: IRI, U.S. Food 16

17 Smart Balance Milks Lead Category in Florida New Note: Special Request is a registered trademark of Farmland Dairies, LLC. Over The Moon is a registered trademark of Dean Intellectual Property Source, Inc. Simply Smart is a registered trademark of H.P. Hood, LLC. Source: IRI, Florida, FY

18 And Captured up to a 10% Share in Northeast Note: Special Request is a registered trademark of Farmland Dairies, LLC. Over The Moon is a registered trademark of Dean Intellectual Property Source, Inc. Simply Smart is a registered trademark of H.P. Hood, LLC. Source: IRI, NY+ NE, FY

19 Smart Balance spreads have a loyal core of heavy users who will be key to building out new categories SB Spread User Base SB Categories Consumed % Consumers 1 72% 2 20% 3 6% 4 2% Heavy users: >6 SB lbs/yr Medium users: 4-6 SB lbs/yr Light users: <3 SB lbs/yr Expansion Opportunity

20 Increasing Items Per Store Building a larger footprint in number of items and categories is essential to meeting long-term goals Net Sales ($M) Avg Number of Items per Store Source: IRI, Company filings & estimates 20

21 Plans for 2010 Objective: Increase average items per store by 4 to 25 Three Tier Spreads Strategy Introduce Smart Balance spreads with calcium and vitamin D and update graphics Launch Bestlife brand spreads Expand distribution of Earth Balance and Smart Balance HeartRight brands Dairy Expansion Expand enhanced milk distribution nationally Complete distribution of sour cream Test market single serve milk Product Development Test olive oils in upstate New York Develop next wave of products for

22 Progress in Developing Innovation Platform Assembled experienced and deep management team Built infrastructure for growth in multiple categories Developed functional foods innovation pipeline Strengthened unique, cash-generating virtual model Established retail relationships and expanded distribution Drove core share growth and increased brand awareness Simplified capital structure and refinanced debt Launched strategic initiative in dairy aisle 22

23 Creating Financial Flexibility Fourth Quarter 2009 refinancing Higher acquisition, capital spending limits Two-year $25 million stock repurchase authorized Lower financial covenant thresholds Leverage under 2X Second Quarter 2010 Organization Realignment Lower cash general & administrative costs One time charge of $3.0 to $3.5 million Ongoing supply chain productivity program Cumulative $10 million savings through

24 Investment Highlights Becoming a leading brand in the broader functional foods sector through a robust product line-up beyond margarine spreads Well positioned to capitalize on the growing healthy foods market and trends like aging population, increasing obesity levels, and general awareness of health issues Only naturally trans fat free margarine on the market with patented technology Grown into the #2 player in the margarine category in just 10 years Virtual company model that generates significant free cash flow and has limited capital requirements Quality and experienced management team with promotional and brand building expertise 24

Stephen Hughes Chairman & Chief Executive Officer. Citi Small & Midcap Conference November 19, 2009

Stephen Hughes Chairman & Chief Executive Officer. Citi Small & Midcap Conference November 19, 2009 Stephen Hughes Chairman & Chief Executive Officer Citi Small & Midcap Conference November 19, 2009 Forward-Looking Statements This presentation may contain forward-looking statements within the meaning

More information

MARGARINE AND SPREADS Fueling your passion for making the best impression. PASSION

MARGARINE AND SPREADS Fueling your passion for making the best impression. PASSION FUELING MARGARINE AND SPREADS Fueling your passion for making the best impression. YOUR PASSION MAKING GREAT IMPRESSIONS. Our passion for foodservice excellence is evident in our hardworking line of margarine

More information

MARGARINE AND SPREADS Fueling your passion for making the best impression. PASSION

MARGARINE AND SPREADS Fueling your passion for making the best impression. PASSION FUELING MARGARINE AND SPREADS Fueling your passion for making the best impression. YOUR PASSION VENTURA FOODS MARGARINE AND SPREADS Performance Quality Taste Value Variety Options Ventura Foods offers

More information

Consumer Wellness in India Growth Ahead

Consumer Wellness in India Growth Ahead 1 Consumer Wellness in India Growth Ahead Indian Health & Wellness industry Valued at over INR 590 bn, growing at CAGR of 18% - 20% p.a. Growth expected to continue. Industry growth being driven by: Increasing

More information

A GLOBAL LEADER IN PERSONALIZED NUTRITION

A GLOBAL LEADER IN PERSONALIZED NUTRITION A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking

More information

Q Investor Kit JANUARY-MARCH 2014

Q Investor Kit JANUARY-MARCH 2014 Q1 2014 Investor Kit JANUARY-MARCH 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco

More information

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018 ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates

More information

Investor Presentation

Investor Presentation Investor Presentation Forward Looking Statements The information presented herein may contain projections, predictions, estimates and other forwardlooking statements within the meaning of Section 27A of

More information

For personal use only

For personal use only Freedom Foods Group Annual General Meeting Presentation Rory J F Macleod, Managing Director & CEO 29 th November 2018 Important Information This presentation is provided for information purposes only.

More information

TRANSFORMATIONS IN THE FOOD INDUSTRY: REDUCING TRANS FAT IN THE DIET. Robert M. Reeves, President Institute of Shortening and Edible Oils

TRANSFORMATIONS IN THE FOOD INDUSTRY: REDUCING TRANS FAT IN THE DIET. Robert M. Reeves, President Institute of Shortening and Edible Oils Agricultural Outlook Forum 2005 Presented Thursday, February 24, 2005 TRANSFORMATIONS IN THE FOOD INDUSTRY: REDUCING TRANS FAT IN THE DIET Robert M. Reeves, President Institute of Shortening and Edible

More information

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014 1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include

More information

An exciting combination in a high growth, high margin Nutrition category. Name of chairman

An exciting combination in a high growth, high margin Nutrition category. Name of chairman An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views

More information

Q Investor Kit JANUARY-JUNE 2014

Q Investor Kit JANUARY-JUNE 2014 Q2 2014 Investor Kit JANUARY-JUNE 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco

More information

Genomic Health. Kim Popovits, Chairman, CEO and President

Genomic Health. Kim Popovits, Chairman, CEO and President Genomic Health Kim Popovits, Chairman, CEO and President Safe Harbor Statement Various remarks that we make in this presentation that are not historical, including those about our future financial and

More information

Food & Beverages Food for a growing world

Food & Beverages Food for a growing world Food & Beverages Food for a growing world Rasmus von Gottberg, Vice President F&B Marketing, Novozymes Christel Thea Jørgensen, Vice President R&D, Novozymes Jeremy Bentham, Go to Market Director, Cargill

More information

DuPont Nutrition & Health Craig Binetti, President

DuPont Nutrition & Health Craig Binetti, President Craig Binetti, President Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this

More information

Value growth in Human Nutrition & Health

Value growth in Human Nutrition & Health Value growth in Human Nutrition & Health Rick Greubel President Human Nutrition & Health US Field Trip September 4, 2014 Safe harbor statement This presentation may contain forward-looking statements with

More information

Meeting consumer expectations: new product development and future opportunities for dairy, lactose and gluten-free

Meeting consumer expectations: new product development and future opportunities for dairy, lactose and gluten-free Meeting consumer expectations: new product development and future opportunities for dairy, lactose and gluten-free Anne Wong-Erven, Senior Consultant 18 th November 2015 Food Matters Live, London STRATEGY

More information

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Second quarter sales up 3.1 percent to record $17.0 billion

More information

DSM Capital Markets Day 2018

DSM Capital Markets Day 2018 DSM Capital Markets Day 2018 Human Nutrition & Health Jeremy Xu President Human Nutrition & Health ROYAL DSM CAPITAL MARKETS DAY LONDON (UK) 20 JUNE 2018 Safe harbor statement This presentation may contain

More information

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

Connect with consumers for life. Introducing new MEG-3 Ultra and life sdha Ultra

Connect with consumers for life. Introducing new MEG-3 Ultra and life sdha Ultra Connect with consumers for life Introducing new MEG-3 Ultra and life sdha Ultra ega-3s are essential for everyone, every day Omega-3 fatty acids play a critical role in supporting human health across different

More information

The Strategic Marketing Institute Working Paper

The Strategic Marketing Institute Working Paper The Strategic Marketing Institute Working Paper The Market for Organic and Fortified Eggs William A. Knudson 2-0104 January 2004 Introduction Eggs are an important part of the American diet. According

More information

Q Investor Kit January December 2014

Q Investor Kit January December 2014 Q4 2014 Investor Kit January December 2014 Highlights for Q4 Sales up for all product areas and operating profit from product areas up by 8% Scandinavian hoarding for snus prior to tax increase in January

More information

Cowen Healthcare Conference

Cowen Healthcare Conference Cowen Healthcare Conference Shire plc March 9, 2010 Michael Cola President, Specialty Pharmaceuticals Our purpose We enable people with life-altering conditions to lead better lives 1 THE SAFE HARBOR STATEMENT

More information

Q Investor Kit JANUARY-JUNE 2013

Q Investor Kit JANUARY-JUNE 2013 Q2 2013 Investor Kit JANUARY-JUNE 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

The acquisition of Fortitech

The acquisition of Fortitech The acquisition of Fortitech Accelerating DSM s strategy to become a full solutions provider in food ingredient blends Investor Relations 8 November 2012 Overview Fortitech at a glance Acquisition rationale

More information

Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS

Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s future

More information

Cowen Healthcare Conference March 12, 2018

Cowen Healthcare Conference March 12, 2018 Cowen Healthcare Conference March 12, 2018 Forward-Looking Statements Some of the statements included in this presentation, particularly those regarding the commercialization and ongoing clinical development

More information

J.P. Morgan Healthcare Conference

J.P. Morgan Healthcare Conference J.P. Morgan Healthcare Conference Shire plc January 10, 2012 Angus Russell Chief Executive Officer Our purpose We enable people with life-altering conditions to lead better lives. THE SAFE HARBOR STATEMENT

More information

14th Biennial Sunflower Conference June Consumer Trends & Usage of Fats & Oils. Charles Aldersey

14th Biennial Sunflower Conference June Consumer Trends & Usage of Fats & Oils. Charles Aldersey 14th Biennial Sunflower Conference June 2003 Consumer Trends & Usage of Fats & Oils Charles Aldersey Contents World Usage of Fats & Oils World Consumption Trends in Fats & oils Domestic Consumer Trends

More information

Influence of healthy eating on market trends. Paul Paquin, Ph.D. INAF, Université Laval, Québec

Influence of healthy eating on market trends. Paul Paquin, Ph.D. INAF, Université Laval, Québec Influence of healthy eating on market trends Paul Paquin, Ph.D. INAF, Université Laval, Québec Key Trends TREND A key trend is one that represents a genuine growth opportunity On which a company can base

More information

GLOBAL PERSPECTIVES: AN OVERVIEW OF THE GLOBAL PROTEIN LANDSCAPE CHRIS SCHMIDT SENIOR CONSUMER HEALTH ANALYST MAY 3-4, 2016

GLOBAL PERSPECTIVES: AN OVERVIEW OF THE GLOBAL PROTEIN LANDSCAPE CHRIS SCHMIDT SENIOR CONSUMER HEALTH ANALYST MAY 3-4, 2016 GLOBAL PERSPECTIVES: AN OVERVIEW OF THE GLOBAL PROTEIN LANDSCAPE CHRIS SCHMIDT SENIOR CONSUMER HEALTH ANALYST MAY 3-4, 2016 INTRODUCTION PROTEIN IN THE PASSPORT UNIVERSE TRENDS IN FORMULATION CONCLUSION

More information

4Q and Full Year 2017 Financial Results Call February 7, 2018

4Q and Full Year 2017 Financial Results Call February 7, 2018 4Q and Full Year 2017 Financial Results Call February 7, 2018 Agenda Topic Welcome Opening Remarks 4Q 2017 Results Commercial Progress Question & Answer Speakers Amy Sullivan, SVP, Corporate Affairs Greg

More information

Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS

Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s

More information

LEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017

LEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017 LEERINK GLOBAL HEALTHCARE CONFERENCE Marino Garcia EVP, Chief Strategy Officer February 15, 2017 SAFE HARBOR STATEMENT This presentation and any statements made for and during any presentation or meeting

More information

27 th Annual J.P. Morgan Healthcare Conference. January 13, 2009

27 th Annual J.P. Morgan Healthcare Conference. January 13, 2009 27 th Annual J.P. Morgan Healthcare Conference January 13, 2009 1 Forward Looking Statements This presentation and any subsequent Q&A may contain forward-looking statements, including with respect to:»

More information

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A Slide 1 Financial update and closing remarks Jesper Brandgaard EVP and CFO RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A Slide 2 Forward-looking statements Novo Nordisk s reports filed with or

More information

Expert support to create cost-effective dairy taste and texture

Expert support to create cost-effective dairy taste and texture Milk Fat Replacers Expert support to create cost-effective dairy taste and texture With the growing trend for healthier food, more and more consumers are looking for lower trans fat options, dairy-free

More information

Corporate presentation. November 2016.

Corporate presentation. November 2016. Corporate presentation November 2016. Zvijezda at glance 440 Employees 70.000 tons Volume sold 120 M Turnover Leading brands in several markets ABOUT US Zvijezda d.d. is proudly cherishing its long and

More information

36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018

36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018 36th Annual J.P. Morgan Healthcare Conference Kevin Conroy, Chairman and CEO January 9, 2018 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section

More information

VITAMINS & SUPPLEMENTS

VITAMINS & SUPPLEMENTS VITAMINS & SUPPLEMENTS 2018 TREND INSIGHT REPORT With a rapidly increasing interest in personal health and wellness, more and more American consumers are incorporating vitamins and supplements as part

More information

For personal use only

For personal use only HY18 Result Presentation 13 February 2018 Dig Howitt Brent Cubis CEO & President CFO HY18 Result highlights Strong momentum across developed markets continues Developed market unit growth up 12% Strengthening

More information

This study provides an evaluation of the impact of the Directive as required under the Directive. The aim of the evaluation is to:

This study provides an evaluation of the impact of the Directive as required under the Directive. The aim of the evaluation is to: Executive Summary The European Parliament and Council adopted Directive 2000/36/EC on 23 June 2000. The aim of the Directive was to allow the use of up to 5% of a limited number of vegetable fats in the

More information

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019 Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019 Planned Enrollment targets achieved in both TRILOGY studies with over 74% of patients randomized at more than 150 clinical sites

More information

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE 37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as

More information

BALCHEM CORPORATION. Q Investor Relations Presentation

BALCHEM CORPORATION. Q Investor Relations Presentation BALCHEM CORPORATION Q4 2017 Investor Relations Presentation Balchem Corporation Balchem develops, manufactures, and markets specialty ingredients that improve and enhance the health and well being of life

More information

Harm de Wildt MD TNI

Harm de Wildt MD TNI Harm de Wildt MD TNI Nutreco Capital Markets Day Derbyshire, UK 17 September 1 2013 Agenda 1 2 3 Market overview Animal Nutrition Europe Animal Nutrition strategic priorities Application Solution Centres

More information

ALLERGAN TO ACQUIRE ZELTIQ FOR $2.47B BEST-IN-CLASS COMPANY IN FAST GROWING BODY CONTOURING SEGMENT

ALLERGAN TO ACQUIRE ZELTIQ FOR $2.47B BEST-IN-CLASS COMPANY IN FAST GROWING BODY CONTOURING SEGMENT ALLERGAN TO ACQUIRE ZELTIQ FOR $2.47B BEST-IN-CLASS COMPANY IN FAST GROWING BODY CONTOURING SEGMENT ALLERGAN CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Statements contained in this presentation

More information

OBALON THERAPEUTICS, INC. (OBLN) The first and only FDA-approved swallowable, gas-filled intragastric balloon for weight loss

OBALON THERAPEUTICS, INC. (OBLN) The first and only FDA-approved swallowable, gas-filled intragastric balloon for weight loss OBALON THERAPEUTICS, INC. (OBLN) The first and only FDA-approved swallowable, gas-filled intragastric balloon for weight loss Forward looking statements Except for statements of historical fact, information

More information

Malaysian Palm Oil Prospects & Opportunities in Pakistan. By Fatimah Zaharah Md Nan Faisal Iqbal Malaysian Palm Oil Council

Malaysian Palm Oil Prospects & Opportunities in Pakistan. By Fatimah Zaharah Md Nan Faisal Iqbal Malaysian Palm Oil Council Malaysian Palm Oil Prospects & Opportunities in Pakistan By Fatimah Zaharah Md Nan Faisal Iqbal Malaysian Palm Oil Council Outline Pakistan Agriculture Sector Domestic Oils and Fats Scenario Palm Oil Trade

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. The US Diabetes Care Devices Market Introduction 1.1. What is Diabetes and it s Types? 2. The US Diabetes Care Devices Market Size, 2007-2013 3. The US Diabetes Care Devices Market

More information

Opportunities for Irish Dairy. An Industry Perspective

Opportunities for Irish Dairy. An Industry Perspective Opportunities for Irish Dairy An Industry Perspective Content 1 2 3 Who we are and what we do Kerry s approach to value creation Responding to opportunities: Recent market innovations 2 Taste & Nutrition

More information

MAJOR DIFFERENCES BETWEEN COBRAM ESTATE EXTRA VIRGIN OLIVE OIL, VIRGIN OLIVE OIL AND OLIVE OIL (REFINED BLENDS)

MAJOR DIFFERENCES BETWEEN COBRAM ESTATE EXTRA VIRGIN OLIVE OIL, VIRGIN OLIVE OIL AND OLIVE OIL (REFINED BLENDS) , VIRGIN OLIVE OIL AND OLIVE OIL (REFINED BLENDS) NATURAL OLIVE OILS OBTAINED BY SOLE MECHANICAL/PHYSICAL MEANS NO ALTERATIONS IN THE OIL REFINED OLIVE OILS REFINING PROCESS LEADS TO ALTERATIONS IN NATURAL

More information

Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free

Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Investor Day EEMA Region Lausanne, September 29, 2016 Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Agenda Overview and Key Results Vision and Strategic Pillars

More information

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce

More information

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes 1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements

More information

Corporate Presentation

Corporate Presentation Corporate Presentation January 2019 2018 Chembio. All Rights Reserved. # 2019 Chembio. All Rights Reserved. Page 1 Safe Harbor Statement Statements contained herein that are not historical facts are forward-looking

More information

STRATEGIC PLAN

STRATEGIC PLAN STRATEGIC PLAN 2019-2028 3 EXECUTIVE SUMMARY Health at the center Good health changes everything. With good health, children can learn, parents can provide and neighbors can work together to build, and

More information

Investor Day LA&C Region Lausanne, September 29, Jeanne Pollès President, Latin America & Canada Region

Investor Day LA&C Region Lausanne, September 29, Jeanne Pollès President, Latin America & Canada Region Investor Day LA&C Region Lausanne, September 29, 2016 Jeanne Pollès President, Latin America & Canada Region Agenda Regional Overview and Performance Regional Strategies Key Markets Conclusion 2 LA&C Regional

More information

Designing a Smoke-Free Future

Designing a Smoke-Free Future Designing a Smoke-Free Future Morgan Stanley Global Consumer & Retail Conference New York, November 14, 2017 Jacek Olczak Chief Financial Officer Martin King President, Asia Region Forward-Looking and

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. Brazil Nutraceuticals Industry Introduction 1.1. Government Rules and Regulations 2. Brazil Nutraceuticals Industry Size by Revenues, 2006-2012 3. Brazil Nutraceuticals Market Segmentation

More information

January 2017 Investor Presentation. confidently live life with ease

January 2017 Investor Presentation. confidently live life with ease January 2017 Investor Presentation confidently live life with ease Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that could

More information

Egalet Corporate Presentation

Egalet Corporate Presentation Egalet Corporate Presentation Specialty Pharmaceutical Company Focused on Pain 1 NASDAQ: EGLT Forward-Looking Statements Statements included in this presentation that are not historical in nature are "forward-looking

More information

Myriad Genetics Corporate Presentation 06/13/2018

Myriad Genetics Corporate Presentation 06/13/2018 Myriad Genetics Corporate Presentation 06/13/2018 Copyright 2016 2018 Myriad Genetics, Inc., all rights reserved. www.myriad.com. 1 Forward Looking Statements Some of the information presented here today

More information

State of the industry: Dairy

State of the industry: Dairy foodbusinessnews.net/articles/12965-state-of-the-industry-dairy State of the industry: Dairy Photo: Adobe Stock 12.06.2018 By Donna Berry 1 KANSAS CITY Probiotic cold-brew latte. Spanish Manchego cheese

More information

Developing & Commercializing Targeted Small Molecule Drugs in Cancer

Developing & Commercializing Targeted Small Molecule Drugs in Cancer Developing & Commercializing Targeted Small Molecule Drugs in Cancer SAFE HARBOR STATEMENT 2 Forward-looking statements made in the course of this presentation are made pursuant to the safe harbor provisions

More information

MILLENNIALS AND ORANGE JUICE CONSUMPTION

MILLENNIALS AND ORANGE JUICE CONSUMPTION MILLENNIALS AND ORANGE JUICE CONSUMPTION Yan Heng, PhD and Lisa House, PhD Presented to the International Citrus Beverage Conference Florida Agricultural Market Research Center Food and Resource Economics

More information

Forward-Looking Statements

Forward-Looking Statements Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.

More information

Expert support to create cost-effective dairy taste and texture

Expert support to create cost-effective dairy taste and texture Milk Fat Replacers Expert support to create cost-effective dairy taste and texture With the growing trend for healthier food, more and more consumers are looking for lower trans fat options, dairy-free

More information

Company Overview February 26, 2019

Company Overview February 26, 2019 Company Overview February 26, 2019 SAFE HARBOR Cautionary Note Regarding Forward-Looking Statements Certain statements in this presentation constitute forward-looking statements, including, without limitation,

More information

NORTH AMERICAN DIETARY SUPPLEMENTS

NORTH AMERICAN DIETARY SUPPLEMENTS NORTH AMERICAN DIETARY SUPPLEMENTS Prepared by: CPL Business Consultants The Manor House, Howbery Park, Wallingford, Oxfordshire, OX10 8BA Tel: +44 1491 822 844, info@cplconsult.com, www.cplconsult.com

More information

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Coloplast has four business areas all with global sales presence Group revenue

More information

Very good Q3 contribution from Vegetable Juices Inc.

Very good Q3 contribution from Vegetable Juices Inc. 2014 nine-month sales (1 st January to 30 September 2014) Very good Q3 contribution from Vegetable Juices Inc. Worldwide economic environment still adverse Sustained growth by Food & Beverage Press release

More information

The Complete Program Provides:

The Complete Program Provides: CATALOG Pharmace is a suite of solutions dedicated exclusively to helping independent community pharmacies. Each program provides professionally created promotional resources and proven-effective nutritional

More information

SAKURA 3 Open-Label Phase 3 Safety Study with DaxibotulinumtoxinA for Injection (RT002) for the Treatment of Moderate to Severe Glabellar Lines

SAKURA 3 Open-Label Phase 3 Safety Study with DaxibotulinumtoxinA for Injection (RT002) for the Treatment of Moderate to Severe Glabellar Lines SAKURA 3 Open-Label Phase 3 Safety Study with DaxibotulinumtoxinA for Injection (RT002) for the Treatment of Moderate to Severe Glabellar Lines Presented by Dan Browne, Co-Founder, President & CEO, and

More information

Avocado Tracking Study

Avocado Tracking Study Avocado Tracking Study 2015 Audience Analysis Prepared by: Hass Avocado Board 230 Commerce, Suite 190 Irvine, CA 92605 www.hassavocadoboard.com Contents Background 3 Summary 6 Detailed Findings Audience

More information

RAI reports strong 2Q16 performance and positive outlook; Accelerates returns to shareholders

RAI reports strong 2Q16 performance and positive outlook; Accelerates returns to shareholders Contact: Investor Relations: Bob Bannon (336) 741-3359 Media: Jane Seccombe (336) 741-5068 Reynolds American Inc. P.O. Box 2990 Winston-Salem, NC 27102-2990 RAI 2016-22 RAI reports strong 2Q16 performance

More information

ResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference

ResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference ResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference Mick Farrell CEO January 8, 2018 Safe Harbor Statement Statements contained in this presentation that are not historical facts are forwardlooking

More information

ADAPTIMMUNE INVESTOR PRESENTATION. August 2016

ADAPTIMMUNE INVESTOR PRESENTATION. August 2016 ADAPTIMMUNE INVESTOR PRESENTATION August 2016 DISCLAIMER This presentation contains forward-looking statements, as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA),

More information

Lars Dahlgren. President and CEO

Lars Dahlgren. President and CEO Lars Dahlgren President and CEO 1 Summing up 2013 Sales in line with last year but decreasing profits Sales +1% Operating profit -5% Earnings per share 13.63 SEK (14.33) Financially challenging year but

More information

Presentation to 2019 JP Morgan Healthcare Conference

Presentation to 2019 JP Morgan Healthcare Conference For immediate release 10 January 2019 Presentation to 2019 JP Morgan Healthcare Conference Please find attached CSL Limited s presentation at the 2019 JP Morgan Healthcare Conference. For further information,

More information

SOYBEAN OIL FACTS CONVENTIONAL SOYBEAN OIL

SOYBEAN OIL FACTS CONVENTIONAL SOYBEAN OIL OIL FACTS CONVENTIONAL OIL Versatile Oil Solution Soybean oil is the most widely used edible oil in the U.S. 1 It blends well with other fats and oils, making it a common ingredient in margarine and shortenings,

More information

Solutions For The Aging Spine

Solutions For The Aging Spine Solutions For The Aging Spine NASDAQ: ATEC February 2009 www.alphatecspine.com Slide 0 5818 El Camino Real, Carlsbad, CA 92008 www.alphatecspine.com Forward Looking Statements This presentation and our

More information

OmegaXanthin. Retailer Reasons to Participate Q2 PROMOTION HIGHLIGHTS

OmegaXanthin. Retailer Reasons to Participate Q2 PROMOTION HIGHLIGHTS Q2 PROMOTION HIGHLIGHTS OmegaXanthin Omega-3 Fish Oil OmegaXanthin Retailer Reasons to Participate 1. Innovative Product Line Huge Growing Category 2. PureMax Highest Quality Fish Oil 3. High Retailer

More information

SPY Imaging for Surgeons

SPY Imaging for Surgeons SPY Imaging for Surgeons Forward-Looking Statements These slides accompany an oral presentation by Novadaq Technologies, Inc., which contains forwardlooking statements. Actual results may differ materially

More information

Shareholder Presentation Annual Meeting 2018

Shareholder Presentation Annual Meeting 2018 Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)

More information

Lena Ingvarsson Marketing Director Dairy. Dairy

Lena Ingvarsson Marketing Director Dairy. Dairy Lena Ingvarsson Marketing Director Dairy Dairy Dairy January to September 90 100 85 80 75 77 84 77 78 87 80 60 40 20 29 66 52 64 77 70 2010 2011 2012 2013 2014 0 2010 2011 2012 2013 2014 Volumes ('000

More information

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 27.6.2007 COM(2007) 360 final REPORT FROM THE COMMISSION TO THE COUNCIL on the evolution of the market in milk products and competing products EN EN REPORT

More information

The Savvy Sales & Marketer s Field Guide to. Fats & Oils. Solutions for Better-for-You Products! 5 th Edition

The Savvy Sales & Marketer s Field Guide to. Fats & Oils. Solutions for Better-for-You Products! 5 th Edition The Savvy Sales & Marketer s Field Guide to Fats & Oils Solutions for Better-for-You Products! 5 th Edition Picture a Successful Product Launch Go ahead, really picture it. Let s say you re launching a

More information

Q Investor Kit JANUARY-MARCH 2013

Q Investor Kit JANUARY-MARCH 2013 Q1 2013 Investor Kit JANUARY-MARCH 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

Business Contributions to Setting New Research Agendas: Business Platform for Nutrition Research (BPNR)

Business Contributions to Setting New Research Agendas: Business Platform for Nutrition Research (BPNR) Business Contributions to Setting New Research Agendas: Business Platform for Nutrition Research (BPNR) Purpose How can we promote more investment into public research? How can we promote improved uptake

More information

Tamsulosin Hydrochloride 0.4 mg Capsule

Tamsulosin Hydrochloride 0.4 mg Capsule Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule

More information

Merrill Lynch conference. Matthew Emmens, CEO Shire plc September 20, 2007

Merrill Lynch conference. Matthew Emmens, CEO Shire plc September 20, 2007 Merrill Lynch conference Matthew Emmens, CEO Shire plc September 20, 2007 THE SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 Statements included herein that are not historical

More information

Consumer Sales Response to Whole Grain Certified Natural Products. Presented by Bobbi Leahy SPINS January 2011

Consumer Sales Response to Whole Grain Certified Natural Products. Presented by Bobbi Leahy SPINS January 2011 Consumer Sales Response to Whole Grain Certified Natural Products Presented by Bobbi Leahy SPINS January 2011 1 Agenda What is SPINS data? 2010- A Whole Grain Year Insights and Trends 2011 2 Who is SPINS?

More information

DARA Reports Year-End 2012 Financial Results

DARA Reports Year-End 2012 Financial Results April 1, 2013 DARA Reports Year-End 2012 Financial Results Company Provides a Commercial Portfolio and Development Pipeline Business Update RALEIGH, NC -- (MARKETWIRE) -- 04/01/13 -- DARA BioSciences,

More information

RAI: Strong key-brands performance delivers 2Q13 profit growth; Company reaffirms full-year EPS guidance

RAI: Strong key-brands performance delivers 2Q13 profit growth; Company reaffirms full-year EPS guidance Contact: Investor Relations: Morris Moore (336) 741-3116 Media: Jane Seccombe (336) 741-5068 Reynolds American Inc. P.O. Box 2990 Winston-Salem, NC 27102-2990 RAI 2013-10 RAI: Strong key-brands performance

More information

Q Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures

Q Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures Q4 2009 Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures and Unit Prices Executive Summary The WHO, in collaboration with IMS, has put in place a programme

More information

GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008

GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008 GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference CEO GN ReSound, Mike van der Wallen September 3, 2008 GN Store Nord A/S GN GN Store Store Nord Nord Listed Listed company

More information

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018 CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm

More information